News and Views
Nature Biotechnology 26, 528 - 529 (2008)
doi:10.1038/nbt0508-528
Retinal anti-angiogenesis by a new route
Roy Bicknell1
-
Roy Bicknell is at the Cancer Research UK Angiogenesis Group, Institute for Biomedical Research, University of Birmingham Medical School, Edgbaston, Birmingham B15 2TT, UK.
e-mail: r.bicknell@bham.ac.uk
Abstract
A regulator of VEGF signaling shows therapeutic potential for retinal disease.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3BOncogene Original Article
Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeabilityNature Medicine Letter (01 Apr 2008)
The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundariesNature Genetics Letter (01 Jul 1998)
